No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BCDAW Biocardia Inc C/Wts 06/08/2024(To Pur Com)
- 0.0127
- -0.0070-35.53%
Close Jul 5 16:00 ET
0Market Cap0.00P/E (TTM)
0.0130High0.0127Low5.89KVolume0.0130Open0.0197Pre Close77.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares1.020052wk High0.00P/B0Float Cap0.005952wk Low--Dividend TTM0Shs Float3.5000Historical High--Div YieldTTM1.52%Amplitude0.0059Historical Low0.0130Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
10-Q: Quarterly report
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
BioCardia Reports Positive Interim Results From Phase III CardiAMP Cell Therapy Heart Failure Trial, With Compelling Data in Subgroup With Elevated NTproBNP Biomarker for Heart Failure
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg